MedTrace Logo

Trochlear Thickness and Its Effect on the Outcomes of Total Knee Arthroplasty

NCT06555055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2024-08-15

No results posted yet for this study

Summary

Total knee arthroplasty (TKA ) is the gold standard treatment for advanced knee osteoarthritis. only 85% (75% to 92%) of patients with total knee arthroplasty are satisfied with their operations and 30% develops patellofemoral complications.

Numerous biomechanical studies suggest that patellofemoral tracking is not always restored to physiological values, because the prosthetic trochlea may differ from the native trochlea. no study has been con-ducted to investigate the thickness of the trochlear groove and its effect on the outcome of Total knee replacement (TKR), So many people has different measurements of trochlear thickness which may affect Patellofemoral joint (PFJ) so knowing of native trochlear thickness in patients with KNEE Osteoarthritis (OA) can affect the outcomes of total knee arthroplasty.

Conditions

Interventions

OTHER

CT trochlear thickness change

Preoperative and postoperative CT scan measuring trochlear thickness of PFJ was defined as distance from deepest part of trochlea and line tangential to the anterior aspect of the femoral cortex. It was assessed on the sagittal cuts. CT images will be viewed using Sante DICOM viewer version 5.4.2 and image fusion will be done using Overlay multiple image software. Two observers will measure the angles and the intraobserver and interobserver reliabilities will be assessed for consistency by the intraclass correlation coefficient (ICC) and reliability coefficient using the SPSS software

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • Ibrahim barsoum

    lead OTHER

Principal Investigators

  • Ibrahim B Anis, MS · Ain Shams University

  • Wael S Abd El Mageed, MD · Ain Shams University

  • Sherif M El Sayed, MD · Ain Shams University

  • Zeiad M Zakaria, MD · Ain Shams University

  • Mohmed E Awad, MD · Ain Shams University

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2024-05-01
Completion
2024-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06555055 on ClinicalTrials.gov